Leukemia Research
Volume 27, Issue 9 , Pages 813-822, September 2003

Expression of IL-18 and its receptor in human leukemia cells

National Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 288 Nanjing Road, Tianjin 300020, PR China

Received 19 July 2002; accepted 13 December 2002.

Abstract 

The importance of IL-18, although clearly established in solid tumors, has not been fully elucidated in human hematopoietic neoplasms. Here we examined the mRNA and protein for IL-18 in eight human hematopoietic cell lines representing different lineages and neoplasms including leukemia, lymphoma and others. Our results revealed that IL-18 mRNA was expressed in these cells and that the corresponding protein was found in the cytoplasm. Seven of eight cell lines were also found to express two subunits of the IL-18 receptor (IL-18R) at varied levels. Furthermore, 29 out of 51 leukemia patients tested were observed to express IL-18R with 18/29 (62%) co-expression of both receptor and ligand. By blocking the IL-18 loop using specific antisense oligodeoxynucleotide (ASON) for IL-18 mRNA or anti-human IL-18R monoclonal antibody (McAbR), we were not able to demonstrate a marked inhibition on the most leukemic cell lines growth. Moreover, the potential proliferation in vitro of primary AML cells co-expressing IL-18 and its receptor was not significantly enhanced by recombinant human IL-18, suggesting that IL-18 is not apparently implicated in the proliferation of the leukemia cells via an autocrine loop. Additionally, we also found the effective modulating effect of M-CSF, IFN-α and TNF-α on IL-18R expression, implying an important in vivo effect of cytokines on IL-18-induced reaction. Moreover, the modulation of IL-18R expression was possibly irrelevant to IFN-γ secretion induced by these cytokines.

Abbreviations: AcPL, IL-1 receptor accessory protein-like protein, ALL, acute lymphocytic leukemia, AML, acute myeloid leukemia, ASON, antisense oligodeoxynucleotide, BMMC, bone marrow mononuclear cells, BSA, bovine serum albumin, CML, chronic myeloid leukemia, ELISA, enzyme-linked immunosorbent assay, FCS, fetal calf serum, GAPDH, glyceraldchyde 3-phosphate dehydrogenase, IFN-α, interferon-α, IL-1Rrp, IL-1R related protein, IRAK, IL-1R associated kinase, M-CSF, macrophage colony stimulating factor, IL-18, interleukin 18, IL-18R, IL-18 receptor, McAbR, anti-human IL-18R monoclonal antibody, PBMC, peripheral blood mononuclear cell, PI, propidium iodide, rhIL-18, recombinant human IL-18, RT-PCR, reverse transcriptase polymerase chain reaction, SON, sense oligodeoxynucleotides, TNF-α, tumor necrosis factor-α

Keywords: IL-18, IL-18 receptor, Autocrine, Modulation, Leukemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(03)00005-5

doi:10.1016/S0145-2126(03)00005-5

Leukemia Research
Volume 27, Issue 9 , Pages 813-822, September 2003